Jimmy Ma, Robin M Nance, Stephanie A Ruderman, Lydia N Drumright, L Sarah Mixson, Felicia C Chow, Joseph Zunt, Christina M Marra, Maile Karris, Emily L Ho, Kyra Becker, Rizwan Kalani, Andrew Huffer, Rob Fredericksen, Sonia Napravnik, Richard D Moore, Barbara Gripshover, Amanda Willig, Jacklyn D Foley, Greer Burkholder, Michael S Saag, Katerina Christopoulos, Mari M Kitahata, David Tirschwell, Joseph A C Delaney, Heidi M Crane
{"title":"Impact of Depressive Symptom Severity on Stroke Risk in a US Cohort of People with HIV.","authors":"Jimmy Ma, Robin M Nance, Stephanie A Ruderman, Lydia N Drumright, L Sarah Mixson, Felicia C Chow, Joseph Zunt, Christina M Marra, Maile Karris, Emily L Ho, Kyra Becker, Rizwan Kalani, Andrew Huffer, Rob Fredericksen, Sonia Napravnik, Richard D Moore, Barbara Gripshover, Amanda Willig, Jacklyn D Foley, Greer Burkholder, Michael S Saag, Katerina Christopoulos, Mari M Kitahata, David Tirschwell, Joseph A C Delaney, Heidi M Crane","doi":"10.1097/QAI.0000000000003710","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Depression is a common psychiatric condition and an independent stroke risk factor among people with HIV (PWH). The impacts of depressive symptom severity on stroke are not clear in PWH.</p><p><strong>Methods: </strong>We studied adult PWH in clinical care at five CNICS sites with ≥1 assessment for depressive symptoms (PHQ-9) from 2010-2022. We used Cox models to evaluate: (1) associations between time-varying depressive symptom severity and adjudicated incident stroke, serially adjusted for clinical factors; (2) modification of this association by age and sex. Participants were followed from 6 months after first CNICS visit or date the CNICS site began stroke adjudication (baseline) (whichever later) until the first stroke, death, loss to follow-up, last clinic visit, or study end.</p><p><strong>Results: </strong>Among 13,817 PWH (mean age 45 years, 19% female, 58% non-white race/ethnicity), 23% screened positive for depression at baseline and 173 had an incident stroke during follow up (mean follow-up 7.6 years). Time-varying depressive symptom severity (per 5-points PHQ-9 score) was associated with higher stroke risk (aHR 1.16, P=0.01) with greater impact in PWH <50y than ≥50y (Interaction P=0.02) but no significant difference by sex. Adjusting for combinations of sociodemographic, cardiovascular, HIV, and substance use factors only slightly attenuated estimates.</p><p><strong>Conclusions: </strong>Depressive symptom severity was an independent risk factor for stroke with higher severity depressive symptoms predicting higher stroke risk and greater impact in PWH <50 years. Depression may be a modifiable risk factor for stroke and should be studied further to understand, develop, and target interventions to reduce stroke risk, especially in younger PWH.</p>","PeriodicalId":520658,"journal":{"name":"Journal of acquired immune deficiency syndromes (1999)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12306592/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of acquired immune deficiency syndromes (1999)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003710","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Depression is a common psychiatric condition and an independent stroke risk factor among people with HIV (PWH). The impacts of depressive symptom severity on stroke are not clear in PWH.
Methods: We studied adult PWH in clinical care at five CNICS sites with ≥1 assessment for depressive symptoms (PHQ-9) from 2010-2022. We used Cox models to evaluate: (1) associations between time-varying depressive symptom severity and adjudicated incident stroke, serially adjusted for clinical factors; (2) modification of this association by age and sex. Participants were followed from 6 months after first CNICS visit or date the CNICS site began stroke adjudication (baseline) (whichever later) until the first stroke, death, loss to follow-up, last clinic visit, or study end.
Results: Among 13,817 PWH (mean age 45 years, 19% female, 58% non-white race/ethnicity), 23% screened positive for depression at baseline and 173 had an incident stroke during follow up (mean follow-up 7.6 years). Time-varying depressive symptom severity (per 5-points PHQ-9 score) was associated with higher stroke risk (aHR 1.16, P=0.01) with greater impact in PWH <50y than ≥50y (Interaction P=0.02) but no significant difference by sex. Adjusting for combinations of sociodemographic, cardiovascular, HIV, and substance use factors only slightly attenuated estimates.
Conclusions: Depressive symptom severity was an independent risk factor for stroke with higher severity depressive symptoms predicting higher stroke risk and greater impact in PWH <50 years. Depression may be a modifiable risk factor for stroke and should be studied further to understand, develop, and target interventions to reduce stroke risk, especially in younger PWH.